Regeneron-Sanofi throat infection drug succeeds key study
October 16, 2017 at 08:17 AM EDT
Oct 16 (Reuters) - Regeneron Pharmaceuticals Inc and Sanofi SA said on Monday their drug to treat patients with a rare throat infection met the main goal of a mid-stage study.
